Market Movers (8-K)
See all →NYSE
United States Antimony Corporation reports significant progress in its 2026 mining campaign at Stibnite Hill, Montana, with ore haulage rates more than doubling compared to the previous year.
NYSE
United States Antimony Corporation announced a $100 million share repurchase program, signaling management's belief that the company's stock is undervalued.
NYSE
United States Antimony Corporation reported a 25% year-over-year revenue decline in Q2 2026 to $7.9 million, primarily due to a 52% drop in realized antimony prices, though zeolite segment revenue surged 110%.
Worse than expected
Delay expected
Capital raise
NYSE
United States Antimony Corporation reported second quarter 2026 results with revenues of $7.9 million, a decrease from the prior year, but saw significant growth in its zeolite segment and progress on DLA contracts.
Capital raise
Worse than expected
NYSE
United States Antimony Corporation announced the date for its second quarter 2026 financial and operating results release and subsequent conference call and webcast.
NYSE
United States Antimony Corporation announces a change in its independent registered public accounting firm due to a merger, engaging Sadler Gibb & Associates, LLC.
Quarterly Earnings (10-Q)
See all →NYSE
United States Antimony Corporation reported a net loss for the second quarter of 2026, with revenues declining significantly in its primary antimony segment, though its zeolite business showed strong growth.
Worse than expected
Capital raise
NYSE
United States Antimony Corporation announced a significant revenue surge and a major $245 million contract with the U.S. Defense Logistics Agency, alongside substantial capital raises and strategic acquisitions, despite increased net losses.
Worse than expected
Capital raise
NYSE
United States Antimony Corporation reports significant revenue growth and a return to profitability in Q2 2025, driven by strong antimony prices and strategic expansions.
Better than expected
Capital raise
NYSE
United States Antimony Corporation reports a significant increase in revenue for Q1 2025, driven by higher antimony prices and increased zeolite sales volume.
Better than expected
Capital raise
NYSE
United States Antimony Corporation's recent 10-Q filing outlines its capital structure, operational performance, and strategic shifts, including the shutdown of its Mexican subsidiary.
Worse than expected
Capital raise
NYSE
United States Antimony Corporation reported a net income of $202,792 for the second quarter of 2024, despite a loss from continuing operations, and announced the shutdown of its Mexican subsidiary.
Annual Reports (10-K)
NYSE
United States Antimony Corporation files an amendment to its 2024 annual report to include the inadvertently omitted Consent of Independent Registered Public Accounting Firm.
Worse than expected
Capital raise
NYSE
United States Antimony Corporation's 2024 annual filing reveals increased revenues and a return to gross profit, driven by higher antimony sales and improved operational efficiencies.
Better than expected
NYSE
United States Antimony Corporation's annual 10-K filing outlines its share structure, recent shutdown of Mexican operations, and financial performance for 2023.
Worse than expected
Capital raise
Insider Trading (Form 4)
See all →NYSE
Lloyd Bardswich, Dir, EVP & Chief Mining Eng and a Director of United States Antimony Corp, purchased 20,000 shares of common stock on September 1, 2026 for $4.63 per share.
NYSE
Joseph A Carrabba, a Director of United States Antimony Corp, purchased 21,300 shares of common stock on September 1, 2026 for $4.72 per share.
NYSE
Blaise A. Aguirre, a Director of United States Antimony Corp, purchased 1,400 shares of common stock on August 31, 2026 for $5.04 per share.
NYSE
Gary C Evans, Chairman & CEO and a Director of United States Antimony Corp, purchased 20,000 shares of common stock on August 28, 2026 for $4.92 per share.
NYSE
Director Jon R. Marinelli acquired 12,500 shares of United States Antimony Corp. common stock for $7.45 per share.
NYSE
United States Antimony Corp CFO Richard R. Isaak reported the sale of 100,000 shares of common stock at $9.75 per share.
Proxy Statements (Def-14A)
NYSE
United States Antimony Corporation schedules its 2026 annual meeting to elect directors and vote on doubling authorized common shares.
Capital raise
NYSE
United States Antimony Corporation has filed a Definitive Proxy Statement (DEFA14A) with the U.S. Securities and Exchange Commission.
NYSE
United States Antimony Corporation is seeking shareholder approval for key corporate changes, including reincorporating from Montana to Texas, expanding its equity incentive plan, and electing directors, ahead of its virtual annual meeting on July 31, 2025.
Worse than expected
NYSE
United States Antimony Corporation is holding its 2024 annual meeting to vote on director elections, amendments to its corporate charter, a potential reverse stock split, an increase in authorized shares, and the ratification of its independent auditor.
Capital raise
Schedule 13D - Activist Investments
NYSE
SCHEDULE: Dugan Family Exits US Antimony Stake
Patrick Dugan and the Estate of Lydia Dugan have filed an exit Schedule 13D, reporting the sale of over 2.3 million shares of United States Antimony Corporation stock and ceasing to be a beneficial owner of more than 5%.
Worse than expected
Schedule 13G - Passive Investments
See all →NYSE
T. Rowe Price Associates, Inc. has filed a Schedule 13G, reporting beneficial ownership of 6.8% of United States Antimony Corp.'s common stock as of June 30, 2026.
NYSE
State Street Corporation and SSGA Funds Management, Inc. have updated their Schedule 13G filing, reporting a combined beneficial ownership of 7.7% in United States Antimony Corp.
NYSE
Van Eck Associates Corporation has reported beneficial ownership of 10,369,695 shares, representing 7.23% of the outstanding common stock of United States Antimony Corp.
NYSE
The Vanguard Group has amended its Schedule 13G filing for United States Antimony Corp, reporting 0% beneficial ownership following an internal realignment.
NYSE
State Street Corporation has reported a passive beneficial ownership of 5.5% in United States Antimony Corp, holding 7,669,026 common shares.
NYSE
BlackRock, Inc. has reported a 5.5% beneficial ownership stake in United States Antimony Corp, holding 6,560,151 shares of common stock as a passive investor.